Article

Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms

2024-01-03

Abstract excerpt

<title>Abstract</title> <p>In 2022, two novel classification systems for myelodysplastic syndromes/neoplasms (MDS) have been proposed: the International Consensus Classification (ICC) and the 2022 World Health Organization (WHO-2022) classification. These two contemporary systems exhibit numerous shared features but also diverge significantly in terminology and the definition of new entities. Thus, we retrospecti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 90a1310e-5f7d-5f82-974a-75620004a7a3
DOI: 10.21203/rs.3.rs-3795533/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/NeoplasmsDOI 10.21203/rs.3.rs-3795533/v1Read

Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53-mutated Myelodysplastic Neoplasms.Semantic proximity Read

Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.Semantic proximity Read

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read

Impact of the International Consensus Classification of myelodysplastic syndromes.Semantic proximity Read

Perspectives on Acute Myeloid Leukemia Diagnosis: A Comparative Analysis of the Latest World Health Organization and the International Consensus ClassificationsSemantic proximity Read

Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.Semantic proximity Read

Diagnosis and classification of myelodysplastic syndromesSemantic proximity Read

Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity Read

The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasmsSemantic proximity Read

The International Consensus Classification of myelodysplastic syndromes and related entities.Semantic proximity Read

Myelodysplastic syndromes, thy name is heterogeneity.Semantic proximity Read

Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms.Semantic proximity Read